Caprock Group LLC Raises Position in Agilent Technologies, Inc. (NYSE:A)

Caprock Group LLC increased its holdings in Agilent Technologies, Inc. (NYSE:AFree Report) by 25.7% in the fourth quarter, Holdings Channel.com reports. The firm owned 9,698 shares of the medical research company’s stock after purchasing an additional 1,982 shares during the period. Caprock Group LLC’s holdings in Agilent Technologies were worth $1,305,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in A. Van ECK Associates Corp boosted its holdings in shares of Agilent Technologies by 6.6% in the 3rd quarter. Van ECK Associates Corp now owns 2,976,905 shares of the medical research company’s stock valued at $442,011,000 after purchasing an additional 183,716 shares during the last quarter. Vestal Point Capital LP acquired a new position in Agilent Technologies in the third quarter valued at $14,848,000. Empowered Funds LLC grew its position in Agilent Technologies by 29.8% during the third quarter. Empowered Funds LLC now owns 30,978 shares of the medical research company’s stock valued at $4,592,000 after acquiring an additional 7,111 shares during the period. S.E.E.D. Planning Group LLC increased its stake in Agilent Technologies by 12.7% during the fourth quarter. S.E.E.D. Planning Group LLC now owns 42,587 shares of the medical research company’s stock worth $5,721,000 after acquiring an additional 4,805 shares during the last quarter. Finally, Czech National Bank raised its holdings in shares of Agilent Technologies by 6.5% in the 3rd quarter. Czech National Bank now owns 59,456 shares of the medical research company’s stock worth $8,828,000 after purchasing an additional 3,612 shares during the period.

Analyst Ratings Changes

A number of research firms recently issued reports on A. Bank of America dropped their target price on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a research report on Friday, December 13th. JPMorgan Chase & Co. cut their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 26th. Barclays reduced their target price on shares of Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating on the stock in a report on Wednesday, November 27th. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, December 24th. Finally, Sanford C. Bernstein lowered their target price on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research note on Tuesday, November 26th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $143.62.

View Our Latest Research Report on Agilent Technologies

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the sale, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at approximately $5,947,800. This represents a 4.60 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Agilent Technologies Price Performance

A stock opened at $151.75 on Monday. The company has a market capitalization of $43.34 billion, a PE ratio of 34.33, a P/E/G ratio of 3.98 and a beta of 1.06. The company has a quick ratio of 1.58, a current ratio of 2.09 and a debt-to-equity ratio of 0.57. The stock’s 50 day moving average is $140.52 and its two-hundred day moving average is $138.81. Agilent Technologies, Inc. has a 52-week low of $124.16 and a 52-week high of $155.35.

Agilent Technologies (NYSE:AGet Free Report) last posted its quarterly earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.05. The firm had revenue of $1.70 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The firm’s quarterly revenue was up .8% on a year-over-year basis. During the same period in the prior year, the company posted $1.38 earnings per share. Analysts predict that Agilent Technologies, Inc. will post 5.56 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st were issued a $0.248 dividend. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.24. This represents a $0.99 annualized dividend and a yield of 0.65%. The ex-dividend date was Tuesday, December 31st. Agilent Technologies’s payout ratio is currently 22.40%.

About Agilent Technologies

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

See Also

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AFree Report).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.